Abstract
Curcumin (diferuloylmethane) is one of the phytophenolic compounds found in the turmeric plant with anti-inflammatory and anticarcinogenic activities. One possible mechanism for these activities is the inhibition of prostaglandin (PG) E2 formation. In this study and other reports, curcumin suppresses interleukin-1β-induced formation of prostaglandin E2 in a concentration-dependent manner. Interleukin-1β-induced microsomal prostaglandin E synthase 1 (mPGES-1) and cyclooxygenase-2 were attenuated by curcumin at the protein and mRNA levels, but a more dramatic inhibition of mPGES-1 expression was observed at lower concentrations of curcumin in A549 human lung epithelial cells. The inhibition of mPGES-1 expression by curcumin shifted the arachidonic acid profile from PGE2 to PGF2α and 6-keto-PGF1α as major metabolites. The expression of early growth response gene 1 (EGR-1), a key transcription factor of cytokine-induced mPGES-1, was inhibited by curcumin. Incubation with siRNA for EGR-1 inhibited interleukin (IL)-1β-induced mPGES-1, and the controlled expression of EGR-1 increased the mPGES-1 expression. Several proinflammatory signaling molecules, such as nuclear factor κB (NF-κB) and mitogen-activated protein kinases, are also known to affect curcumin-regulated gene expression. Curcumin inhibited IκBα phosphorylation and degradation and thus reduced the expression of mPGES-1. Curcumin suppressed cytokine-induced mPGES-1 by inhibiting phosphorylation of Jun N-terminal kinase (JNK)1/2. However, EGR-1 expression was suppressed by lower concentrations of curcumin, as compared with JNK1/2 and IκBα. These results indicate that curcumin inhibits IL-1β-induced PGE2 formation by inhibiting the expression of mPGES-1 that is mediated by suppression of EGR-1 expression as well as NF-κB and JNK1/2.
Footnotes
-
This research was supported (in part) by the Intramural Research Program of the National Institutes of Health, National Institute of Environmental Health Sciences.
-
Article, publication date, and citation information can be found at http://jpet.aspetjournals.org.
-
doi:10.1124/jpet.105.084434.
-
ABBREVIATIONS: PG, prostaglandin; PGES, prostaglandin E synthase; COX, cyclooxygenase; mPGES-1, microsomal prostaglandin E synthase 1; NF-κB, nuclear factor κB; AP-1, activator protein-1; EGR-1, early growth response gene-1; IL, interleukin; JNK1/2, Jun N-terminal kinase 1/2; SP600125, anthra[1,9-cd]pyrazol-6(2H)-one 1,9-pyrazoloanthrone; MTS, 3-(4,5-dimethylthiazol-2-yl)-5-(3-carboxymethoxyphenyl)-2-(4-sulfophenyl)-2H-tetrazolium; PCR, polymerase chain reaction; TBST, Tris-buffered saline plus Tween 0.05%; RT-PCR, reverse transcription-polymerase chain reaction; UNG, uracil N-glycosylase; HPLC, high-performance liquid chromatography; ANOVA, analysis of variance; SNK, Student-Newman-Keuls; MAP, mitogen-activated protein; SRE, serum response element(s); PPARγ, peroxisome proliferator-activated receptor γ.
-
↵1 1-10 Department of Microbiology and Immunology, Pusan National University Medical School and Medical Research Institute, Busan Republic of Korea.
- Received February 2, 2005.
- Accepted August 1, 2005.
- The American Society for Pharmacology and Experimental Therapeutics
JPET articles become freely available 12 months after publication, and remain freely available for 5 years.Non-open access articles that fall outside this five year window are available only to institutional subscribers and current ASPET members, or through the article purchase feature at the bottom of the page.
|